Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rock

Showing results (351-360 of 367) with videos related to

Pageof 37
Sort By:
Molecular Pharmaceutics|June 2, 2016
Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and TolerabilityKevin J Hamblett, Tiep Le, Brooke M Rock, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Poly-2-methyl-2-oxazoline-modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degenerationAndrey Zakharchenko, Yingfei Xue, Samuel Keeney, et al.
Journal of Molecular Biology|May 22, 2007
The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domainHongzhuang Peng, Lisa C Gibson, Allan D Capili, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 20, 2022
Diabetes and COVID-19: Short- and Long-Term ConsequencesCharlotte Steenblock, Mohamed Hassanein, Emran G Khan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 16, 2008
Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplementsR S Foti, L J Dickmann, J A Davis, et al.
Pediatrics|September 3, 2002
Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcomeClaude J Migeon, Amy B Wisniewski, John P Gearhart, et al.
JMIR Research Protocols|September 6, 2013
Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled TrialJohn W McGillicuddy, Mathew J Gregoski, Anna K Weiland, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2012
Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptorsRobert S Foti, Josh T Pearson, Simon L Wong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 21, 2012
Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzymeKirk R Henne, Thuy B Tran, Brooke M VandenBrink, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2015
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White PaperEugenia Kraynov, Amrita V Kamath, Markus Walles, et al.
Pageof 37

Showing results (351-360 of 367) with videos related to

Sort By:
Pageof 37
Molecular Pharmaceutics|June 2, 2016
Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and TolerabilityKevin J Hamblett, Tiep Le, Brooke M Rock, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Poly-2-methyl-2-oxazoline-modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degenerationAndrey Zakharchenko, Yingfei Xue, Samuel Keeney, et al.
Journal of Molecular Biology|May 22, 2007
The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domainHongzhuang Peng, Lisa C Gibson, Allan D Capili, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 20, 2022
Diabetes and COVID-19: Short- and Long-Term ConsequencesCharlotte Steenblock, Mohamed Hassanein, Emran G Khan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 16, 2008
Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplementsR S Foti, L J Dickmann, J A Davis, et al.
Pediatrics|September 3, 2002
Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcomeClaude J Migeon, Amy B Wisniewski, John P Gearhart, et al.
JMIR Research Protocols|September 6, 2013
Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled TrialJohn W McGillicuddy, Mathew J Gregoski, Anna K Weiland, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2012
Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptorsRobert S Foti, Josh T Pearson, Simon L Wong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 21, 2012
Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzymeKirk R Henne, Thuy B Tran, Brooke M VandenBrink, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2015
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White PaperEugenia Kraynov, Amrita V Kamath, Markus Walles, et al.
Pageof 37